Sleep Tech Firm Launches Clinical Sleep Coaching Subscription Service
Platform integrates CBT-I protocols with real-time biometric monitoring to address growing sleep disorder crisis affecting 50-70 million Americans
SAN FRANCISCO, Nov. 26, 2025— Somnus Health Technologies today launched its Clinical Sleep Coaching Subscription Service, a first-of-its-kind platform that combines evidence-based cognitive behavioral therapy for insomnia (CBT-I) with artificial intelligence-driven biometric analysis and live coaching from board-certified sleep specialists. The service enters a rapidly expanding market valued at USD 1.5 billion in 2025, driven by rising insomnia rates and increased awareness of sleep’s critical role in chronic disease management.
The subscription service addresses a critical gap in sleep healthcare: while 30% of adults report chronic insomnia symptoms, fewer than 5% receive clinically validated treatment. Somnus’ platform delivers personalized sleep interventions through a hybrid model that merges the scalability of digital health apps with the clinical rigor of one-on-one therapy. Users receive a FDA-cleared wearable device that tracks heart rate variability, respiratory patterns, and sleep architecture, with data fed into a proprietary AI engine that identifies behavioral and physiological disruptors. According to recent market analysis, the global sleep coaching market is projected to reach USD 5.1 billion by 2034, expanding at a 14.4% compound annual growth rate as consumers demand solutions that go beyond basic tracking to deliver measurable health outcomes . The CBT-I-based segment alone accounted for 62.7% of market share in 2024, reflecting strong clinical validation and provider adoption.
“Our platform represents a fundamental shift from passive monitoring to active, clinician-supervised intervention,” said Dr. Rebecca Chung, co-founder and CEO of Somnus Health Technologies. “We’re bridging the gap between the 89% of consumers who use sleep trackers and the less than 10% who actually achieve lasting improvement. By embedding board-certified sleep coaches directly into the care pathway, we’re delivering outcomes that meet clinical standards while maintaining the accessibility and affordability that digital health promises.”
The service launches with a network of 50 licensed sleep coaches, each holding credentials from the American Board of Sleep Medicine or Behavioral Sleep Medicine certification. Following an initial 45-minute clinical intake, subscribers receive a customized 12-week CBT-I protocol delivered through weekly video sessions and daily app-based exercises. The AI component continuously analyzes biometric data to adjust intervention intensity, flag potential sleep apnea or restless leg syndrome, and escalate cases to somnologists when polysomnography is indicated. Early beta testing with 2,300 users showed an average 45-minute increase in total sleep time and 30% reduction in sleep onset latency within eight weeks.
Somnus Health Technologies has raised $47 million in Series B funding led by Andreessen Horowitz, with participation from Mayo Clinic Ventures and Kaiser Permanente Ventures. The subscription is priced at $149 monthly, including the wearable device, unlimited app access, and four 30-minute coaching sessions per month—positioning it between premium wellness apps ($15-30/month) and traditional sleep clinic programs ($300-500/month). The company will initially target employer wellness programs and direct-to-consumer channels, with plans to pursue FDA clearance for its AI-driven sleep apnea screening algorithm in Q2 2026.
About Somnus Health Technologies
Founded in 2021 by sleep medicine specialists from Stanford Sleep Medicine Center and AI engineers from Google Health, Somnus Health Technologies develops clinically validated digital therapeutics for sleep disorders. The company’s platform has been validated in five peer-reviewed studies and is used by over 40,000 patients through partnerships with health systems and self-insured employers. Headquartered in San Francisco, Somnus is backed by $62 million in total funding and employs 85 people across engineering, clinical, and data science teams.
Media Contact
Sarha Al-Mansoori
Director of Corporate Communications
G42
Email: media@g42.ai
Phone: +971 2555 0100
Website: www.g42.ai
